Cargando…
Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
Background: Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+. Object...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496080/ https://www.ncbi.nlm.nih.gov/pubmed/28640661 http://dx.doi.org/10.1080/16549716.2017.1330915 |
_version_ | 1783247897213534208 |
---|---|
author | Domercant, Jean Wysler Puttkammer, Nancy Young, Paul Yuhas, Krista François, Kesner Grand’Pierre, Reynold Lowrance, David Adler, Michelle |
author_facet | Domercant, Jean Wysler Puttkammer, Nancy Young, Paul Yuhas, Krista François, Kesner Grand’Pierre, Reynold Lowrance, David Adler, Michelle |
author_sort | Domercant, Jean Wysler |
collection | PubMed |
description | Background: Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+. Objective: To assess attrition among pregnant and non-pregnant patients initiating ART following adoption of Option B+ in Haiti. Methods: Longitudinal data of adult patients initiated on ART from October 2012 through August 2014 at 73 health facilities across Haiti were analyzed using a survival analysis framework to determine levels of attrition. The Kaplan–Meier method and Cox proportional hazards regression were used to examine risk factors associated with attrition. Results: Among 17,059 patients who initiated ART, 7627 (44.7%) were non-pregnant women, 5899 (34.6%) were men, and 3533 (20.7%) were Option B+ clients. Attrition from the ART program was 36.7% at 12 months (95% CI: 35.9–37.5%). Option B+ patients had the highest level of attrition at 50.4% at 12 months (95% CI: 48.6–52.3%). While early HIV disease stage at ART initiation was protective among non-pregnant women and men, it was a strong risk factor among Option B+ clients. In adjusted analyses, key protective factors were older age (p < 0.0001), living near the health facility (p = 0.04), having another known HIV-positive household member (p < 0.0001), having greater body mass index (BMI) (p < 0.0001), pre-ART counseling (p < 0.0001), and Cotrimoxazole prophylaxis during baseline (p < 0.01). Higher attrition was associated with rapidly starting ART after enrollment (p < 0.0001), anemia (p < 0.0001), and regimen tenofovir+lamivudine+nevirapine (TDF+3TC+NVP) (p < 0.001). Conclusions: ART attrition in Haiti is high among adults, especially among Option B+ patients. Identifying newly initiated patients most at risk for attrition and providing appropriate interventions could help reduce ART attrition. |
format | Online Article Text |
id | pubmed-5496080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-54960802017-07-11 Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti Domercant, Jean Wysler Puttkammer, Nancy Young, Paul Yuhas, Krista François, Kesner Grand’Pierre, Reynold Lowrance, David Adler, Michelle Glob Health Action Original Article Background: Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+. Objective: To assess attrition among pregnant and non-pregnant patients initiating ART following adoption of Option B+ in Haiti. Methods: Longitudinal data of adult patients initiated on ART from October 2012 through August 2014 at 73 health facilities across Haiti were analyzed using a survival analysis framework to determine levels of attrition. The Kaplan–Meier method and Cox proportional hazards regression were used to examine risk factors associated with attrition. Results: Among 17,059 patients who initiated ART, 7627 (44.7%) were non-pregnant women, 5899 (34.6%) were men, and 3533 (20.7%) were Option B+ clients. Attrition from the ART program was 36.7% at 12 months (95% CI: 35.9–37.5%). Option B+ patients had the highest level of attrition at 50.4% at 12 months (95% CI: 48.6–52.3%). While early HIV disease stage at ART initiation was protective among non-pregnant women and men, it was a strong risk factor among Option B+ clients. In adjusted analyses, key protective factors were older age (p < 0.0001), living near the health facility (p = 0.04), having another known HIV-positive household member (p < 0.0001), having greater body mass index (BMI) (p < 0.0001), pre-ART counseling (p < 0.0001), and Cotrimoxazole prophylaxis during baseline (p < 0.01). Higher attrition was associated with rapidly starting ART after enrollment (p < 0.0001), anemia (p < 0.0001), and regimen tenofovir+lamivudine+nevirapine (TDF+3TC+NVP) (p < 0.001). Conclusions: ART attrition in Haiti is high among adults, especially among Option B+ patients. Identifying newly initiated patients most at risk for attrition and providing appropriate interventions could help reduce ART attrition. Taylor & Francis 2017-06-22 /pmc/articles/PMC5496080/ /pubmed/28640661 http://dx.doi.org/10.1080/16549716.2017.1330915 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Domercant, Jean Wysler Puttkammer, Nancy Young, Paul Yuhas, Krista François, Kesner Grand’Pierre, Reynold Lowrance, David Adler, Michelle Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
title | Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
title_full | Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
title_fullStr | Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
title_full_unstemmed | Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
title_short | Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti |
title_sort | attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of option b+ in haiti |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496080/ https://www.ncbi.nlm.nih.gov/pubmed/28640661 http://dx.doi.org/10.1080/16549716.2017.1330915 |
work_keys_str_mv | AT domercantjeanwysler attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT puttkammernancy attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT youngpaul attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT yuhaskrista attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT francoiskesner attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT grandpierrereynold attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT lowrancedavid attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti AT adlermichelle attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti |